Abstracts Archive - Page 386 of 1683 - ATC Abstracts

2020 American Transplant Congress
Liver Biopsy Does Not Change Transplant Candidacy Decisions for Hepatitis B Virus Positive Living Donor Kidney Transplant Recipients
C. Baek, H. Kim, S. Park
Asan Medical Center, Seoul, Korea, Republic of
*Purpose: Hepatitis B virus (HBV) infection of kidney transplantation (KT) recipients is associated with increased overall mortality and progression of liver disease after KT. Liver…
2020 American Transplant Congress
Risk of Histological Relapse in Patients with Monoclonal Gammopathy of Renal Significance after Kidney Transplantation
A. Bentall¹, C. Heybeli², F. G. Cosio¹, M. El Ters¹, N. Leung¹, M. P. Alexander³
¹Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, ²Department of Internal Medicine, Dokuz Eylul University, Izmir, Turkey, ³Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
*Purpose: There is increased recognition of Monoclonal Gammopathy of Renal Significance (MGRS) but data on kidney transplant (ktx)outcomes are lacking. We assessed KTX outcomes of…
2020 American Transplant Congress
Free Fatty Acids and Delayed Graft Function after Kidney Transplantation: A Single Center Analysis
J. Zhou¹, J. Lyu¹, X. Yu¹, C. Wu², J. Chen¹
¹The First Affiliated Hospital Kidney Disease Center, College of Medicine, Zhejiang University, Hangzhou, China, ²Global Health Research Center, Duke Kunshan University, Kunshan, China
*Purpose: Delayed graft function (DGF) is one of the most common obstacles of donation after circulatory death (DCD) kidney transplantation. Serum free fatty acids (FFAs)…
2020 American Transplant Congress
Delayed Graft Function Predicts High Risk of Allograft Loss Following Living and Deceased Donor Pediatric Kidney Transplantation
M. MacConmara¹, J. Gattineni¹, D. Desai¹, J. Parekh², P. Vagefi¹, C. S. Hwang¹
¹UT Southwestern, Dallas, TX, ²UC San Diego, San Diego, CA
*Purpose: Pediatric kidney recipients receive high quality living and deceased donor kidneys for transplantation, and as such, these kidneys have a low rate of delayed…
2020 American Transplant Congress
Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Therapy Prior to Kidney Transplantation Does Not Impact Recovery of Function
G. R. Bohan¹, J. Trofe-Clark¹, T. Fallah¹, M. Norris¹, R. D. Bloom², D. Sawinski², G. Malat¹
¹Pharmacy, Hosp of Univ of Pennsylvania, Philadelphia, PA, ²Renal Div, Univ of Pennsylvania, Philadelphia, PA
*Purpose: The impact of chronically administered medications for renin-angiotensin-aldosterone blockade (e.g. ACE-I, ARB), taken prior to kidney transplant (KTx), on immediate allograft function is unknown.*Methods:…
2020 American Transplant Congress
The Long Term Impact of Metabolic Syndrome on Post-Donation in Living Kidney Donors
C. Chen, T. Yu, Y. Chuang, S. Tsai, M. Wu
Division of Nephrology, Taichung Veterans General Hospital, Taichung, Taiwan
*Purpose: The long waiting list for kidney transplant (KTx) in Taiwan, the willingness of transplant centers increase to accept complex donors, eg. metabolic syndrome (MS).…
2020 American Transplant Congress
Cigarette Smoking and Long-Term Renal Function and Cardiovascular Disease in Living Kidney Donors
S. Getsin¹, M. Waldram¹, Y. Yu¹, D. Brennan¹, F. Al Ammary¹, J. Garonzik-Wang¹, M. Henderson¹, J. Locke², R. Reed², K. Lentine³, D. Segev¹, A. Massie¹
¹Johns Hopkins School of Medicine, Baltimore, MD, ²University of Alabama at Birmingham School of Medicine, Birmingham, AL, ³Saint Louis University School of Medicine, St. Louis, MO
*Purpose: Since cigarette smoking is a major risk factor for kidney and cardiovascular disease in the general population, many programs advise living kidney donor candidates…
2020 American Transplant Congress
Non- Superior Patient and Death-Censored Graft Survival with Controlled after Cardiac Death Donors Than Expanded Criteria Brain Death Donors in Older Recipients Over 60 Years, with Better Outcomes with Living Kidney Donors
I. Revuelta¹, D. Cucchiari¹, A. Ruiz², E. De Sousa-Amorim¹, D. Paredes², L. Peri³, P. Ventura-Aguiar¹, M. Musquera³, N. Esforzado¹, F. Cofan¹, J. V. Torregrosa¹, G. J. Piñeiro¹, J. Ugalde-Altamirano¹, J. M. Campistol¹, F. Oppenheimer¹, F. Diekmann¹
¹Renal Transplant Unit, Department of Nephrology and Kidney Transplant, Hospital Clinic, Barcelona, Spain, ²Donation and Transplant Coordination Section, Hospital Clinic, Barcelona, Spain, ³Department of Urology, Hospital Clinic, Barcelona, Spain
*Purpose: Each time transplant candidates are older, and the allocation of suitable donors is a real challenge. Controlled Donors after Cardiac Death (cDCD) are using…
2020 American Transplant Congress
Successful Transplantation Outcomes Utilizing Deceased Donorswith Acute Kidney Injury
A. Harshman, L. Preczewski, M. Muldoon, G. Guerra
Kidney and Kidney/Pancreas Transplant, Miami Transplant Institute, Miami, FL
*Purpose: Kidneys from deceased donors with acute kidney injury (AKI) are discarded at a higher rate than those without AKI, exacerbating the organ shortage crisis.…
2020 American Transplant Congress
Can HLA-DQ Molecular Mismatch Analysis Be Used to Predict Generation of De Novo Donor-Specific Antibody at an Individual Patient Level?
D. Pinelli¹, M. Casillas Abundis¹, R. Hod Dvorai², H. McDowell¹, A. R. Tambur¹
¹Northwestern University, Chicago, IL, ²SUNY Upstate Medical University, Syracuse, NY
*Purpose: De novo donor-specific antibodies (dnDSA), especially to HLA-DQ, are one of the leading causes of late kidney graft failure. Many investigators have attempted to…